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Abstract 
Introduction: An increasing body of evidence has linked diabetes to inflammation. The phosphatidylinositol 3-kinase delta (PI3-K delta), 
a member of the PI3K class IA family, has been implicated in the regulation of inflammation since it is predominantly expressed in leuko-
cytes. To date, no information has been available on the relationship of leukocyte PI3-K delta with gestational diabetes mellitus (GDM). 
Therefore, the aim of this study was to investigate changes in leukocyte PIK3CD mRNA expression in GDM women and, in turn, to cor-
relate them with anthropometric and metabolic parameters of patients. Additionally, an association between leukocyte mRNA expression 
of PIK3CD and Sirtuin 1 (SIRT1) was determined.
Material and methods: Blood samples from women with normal glucose tolerance (NGT; n = 43) and GDM (n = 132) at 24–33 weeks of 
gestation were collected. After isolating leukocytes from the blood, quantitative real time PCR (qRT-PCR) was performed to determine 
PIK3CD gene expression in these cells. Univariate regression analyses were used to assess an association of leukocyte PIK3CD mRNA 
level with clinical characteristics of patients as well as with leukocyte SIRT1 mRNA expression.
Results: Leukocyte PIK3CD mRNA was increased by 1.98-fold in the GDM v. NGT subjects and inversely correlated with low-density 
lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in diabetic pregnancy. There were also significant positive correlations of leu-
kocyte PIK3CD mRNA with plasma glucose concentration at 2h of 75 g oral glucose tolerance test (OGTT) and SIRT1 mRNA in the whole 
study population (both P < 0.05).
Conclusions: GDM is accompanied by leukocyte PIK3CD overexpression associated with reduced plasma LDL-C and TC levels, as well 
as with hyperglycaemia and elevated leukocyte SIRT1 mRNA. (Endokrynol Pol 2014; 65 (1): 17–24)
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Streszczenie
Wstęp: Coraz więcej dowodów wskazuje na związek cukrzycy ze stanem zapalnym. Kinaza 3-fosfatydyloinozytolu delta(PI3-K delta), 
członek klasy IA rodziny kinaz 3-fosfatydyloinozytolu, ulega ekspresji głównie w leukocytach i bierze udział w regulacji odpowiedzi 
immunologicznej. Do tej pory brak jest informacji o związku leukocytarnej PI3-K delta z cukrzycą ciążową (GDM). Dlatego celem ba-
dania było określenie zmian w poziomie ekspresji PIK3CD mRNA w leukocytach kobiet z GDM i skorelowanie ich z antropometrycz-
nymi i metabolicznymi parametrami pacjentek. Dodatkowo zbadano związek między poziomem ekspresji PIK3CD a sirtuiny 1 (SIRT1) 
w leukocytach pacjentek. 
Materiał i metody: Próbki krwi pobrano od kobiet z prawidłową gospodarką węglowodanową (NGT; n = 43) oraz od kobiet z GDM (n 
= 132) w 24.–33. tygodniu ciąży. Po wyizolowaniu leukocytów z krwi, poziom ekspresji PIK3CD mRNA w tych komórkach określono 
metodą ilościowego RT-PCR. Korelacje między ekspresją PIK3CD a klinicznymi parametrami pacjentek i ekspresją SIRT1 analizowano 
z wykorzystaniem regresji jednokrotnych. 
Wyniki: Ekspresja PIK3CD była 1,98-krotnie wyższa w leukocytach kobiet z GDM niż w grupie kontrolnej (P < 0.05) i ujemnie korelowała 
ze stężeniem cholesterolu (TC) i frakcji LDL-C w grupie GDM. Stwierdzono również istotne statystycznie dodatnie korelacje między 
ekspresją PIK3CD a stężeniem glukozy w osoczu w 2. godzinie testu doustnego obciążenia 75-g glukozy (OGTT) i ekspresją SIRT1 w całej 
badanej populacji pacjentek (P < 0.05). 
Wniosk: Cukrzycy ciążowej towarzyszy podwyższona ekspresja PIK3CD w leukocytach, która wiąże się z obniżonymi stężeniami LDL-C 
i TC w osoczu pacjentek oraz hiperglikemią i podwyższonym poziomem SIRT1 mRNA w leukocytach. (Endokrynol Pol 2014; 65 (1): 17–24)
Słowa kluczowe: kinaza 3-fosfatydyloinozytolu delta (PI3-K delta); cukrzyca ciążowa (GDM); sirtuina 1 (SIRT1)
This study was supported financially by funds from the Medical University of Lodz (projects no. 502-03/0-160-01/502-04-002 and 503/1-107-
02/503-01).
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Introduction
Gestational diabetes mellitus (GDM) is defined as car-
bohydrate intolerance that begins or is first recognised 
during pregnancy [1]. This metabolic disorder is an 
increasing health problem among pregnant women in 
the world that affects 1–14% of all pregnancies, depend-
ing on the diagnostic and screening criteria [1, 2]. GDM 
is associated with numerous and serious complications 
for both mother (i.e. preeclampsia, preterm delivery, 
Caesarean section, pregnancy-induced hypertension 
as well as elevated risk of developing type 2 diabetes 
and cardiovascular disease after pregnancy) and foetus 
(i.e. prematurity, macrosomia, hypoglycaemia, jaundice, 
respiratory distress syndrome, polycythemia, and hy-
pocalcaemia) [3]. 
Insulin resistance and pancreatic b-cell dysfunction 
are considered as two major determinants of GDM 
development [2]. Although the pathophysiology of 
GDM is still obscure, defective insulin signalling in 
adipocytes, muscle, and placenta of GDM subjects ap-
pears to be one of the cellular mechanisms underlying 
insulin resistance during maternal diabetic pregnancy 
[4, 5]. Of insulin signalling components, dysregulation 
of phosphatidylinositol 3-kinase (PI3-K) from the class 
IA has been demonstrated as an essential disturbance 
linked to impaired insulin-stimulated glucose transport 
in these tissues during GDM [4, 5]. 
Class IA PI3-Ks are heterodimers consisting of a 110-
kDa catalytic subunit and an 85-kDa regulatory subunit, 
which convert phosphatidylinositol-4,5-bisphosphate 
(PIP2) to phosphatidylinositol-3,4,5-triphosphate 
(PIP3). PIP3 is a second messenger in insulin signal-
ling cascade that is required to propagate downstream 
signalling to protein kinase B (PKB)/Akt and/or atypical 
protein kinase C (PKC), and glucose transport. To date, 
three catalytic subunit isoforms, called PI3-K alpha, 
PI3-K beta and PI3-K delta, and encoded by three 
separate genes, denoted PIK3CA, PIK3CB and PIK3CD 
respectively, have been identified. The PI3-K alpha and 
PI3-K beta isoforms are ubiquitously expressed, whereas 
PI3-Kdelta expression predominates in leukocytes [6]. 
Although the expression profiles of these catalytic subu-
nits have been extensively studied in many different cell 
types, their precise roles and contributions in metabolic 
disorders, including diabetes, are still poorly under-
stood. In recent years, several studies have investigated 
metabolic functions of the PI3-K alpha and/or PI3-K 
beta isoforms in vivo. In this regard, an essential role of 
PI3-K alpha in insulin signalling as well as in the regula-
tion of hepatic glucose and lipid metabolism has been 
shown [7]. Interestingly, no changes in the expression of 
PI3-K alpha and PI3-K beta have been detected in adi-
pose tissues and skeletal muscles of GDM subjects [5].
Thus, these various observations regarding PI3-K alpha 
may be related at least in part to its tissue-specific effects. 
Taking into account a substantial role of leukocytes 
in metabolic dysfunctions during diabetic pregnancy 
and, on the other hand, the fact that PI3-K delta is a cru-
cial regulator of innate and adaptive immune responses 
that is predominantly expressed in leukocytes [8], the 
main objective of the present study was to investigate 
changes in leukocyte PI3KCD mRNA expression in 
the GDM subjects v.normal glucose tolerant (NGT) 
pregnant women and, in turn, to correlate them with 
clinical characteristics of patients. Moreover, we sought 
to determine the relationship between the expression of 
PI3KCD and Sirtuin 1 (SIRT1) in leukocytes of the GDM 
patients since SIRT1 has received significant attention 
as a key NAD+-dependent deacetylase linking caloric 
restriction to mammalian cell life span, insulin secretion, 
and glucose/lipid metabolism [9, 10].
Material and methods
Subject recruitment
One hundred and thirty-two GDM and 43 NGT preg-
nant women between 24 and 33 weeks of gestation were 
recruited for this study during their first visit at the 
Polish Mothers’ Memorial Hospital Research Institute, 
Diabetological Medical Centre in Lodz, Poland. GDM 
was diagnosed if one or more plasma glucose levels 
were elevated during a 75 g, 2 h oral glucose tolerance 
test (OGTT), according to the Polish Diabetes Associa-
tion (PDA; modified WHO criteria) [11]. The inclusion 
criteria were the following:
 — diagnosis of GDM according to the criteria set by 
PDA,
 — Caucasian ethnicity,
 — age between 18 and 40 years,
 — no family history of diabetes within first-degree 
relatives,
 — no GDM in a previous pregnancy,
 — absence of pre-pregnancy diabetes,
 — absence of concomitant systemic disease (chronic or 
acute or infectious). 
All clinical investigations were conducted in accord-
ance with the guidelines of The Declaration of Helsinki 
and were approved by the Ethical Committee of the 
Medical University of Lodz (No. RNN/154/09/KB from 
21.04. 2009). Informed consent was obtained from all 
participating subjects. 
Anthropometric and biochemical measurements 
Information on maternal age and pre-pregnancy weight 
were collected from medical records. The weight and 
height of patients during pregnancy were measured 
using standard methods, and body weight gain as 
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well as pre- and pregnancy body mass index (BMI), 
expressed as weight (before pregnancy or during 
pregnancy) divided by squared height (kg/m2), were 
calculated. Gestational age was established based on 
the last menstrual period.
Blood samples were drawn after a 12 h overnight fast. 
Serum triglycerides (TGs), HDL-cholesterol (HDL-C) 
and LDL-cholesterol (LDL-C) levels were determined by 
enzymatic colorimetric methods using triglyceride GPO-
PAP and the Total Cholesterol CHOD-PAP kits (Roche 
Diagnostics GmbH, Mannheim, Germany). The glycated 
haemoglobin (HbA1C) was measured by a latex-enhanced 
turbidimetric immunoassay using specific monoclonal 
antibodies. The C reactive protein (CRP) concentration 
was determined by turbidimetric assay with the use of 
the cassette COBAS INTEGRA C-Reactive Protein (Latex) 
according to the manufacturer’s instructions (Roche 
Diagnostics GmbH, Mannheim, Germany).
The biochemical assays were carried out with 
a COBAS INTEGRA analyzer (Roche, SA). Plasma in-
sulin level was quantified using Elecsys insulin assay 
(Roche Diagnostics GmbH, Mannheim, Germany). 
Insulin resistance and b-cell function were estimated 
by the homeostasis model assessment, HOMA–IR and 
HOMA–B, respectively [12]:
HOMA–IR = [fasting insulin (µU/mL) × fasting 
glucose (mg/dL)]/405
HOMA–B = [360 × fasting insulin (µU/mL)]/ 
-[fasting glucose (mg/dL) – 63]
Leukocytes separation
Fresh anti-coagulated blood samples (10 mL) withdrawn 
from each patient were centrifuged at 3,000 rpm for 
10 min at 4°C. The supernatants containing plasma 
were discarded, and 15 mL of red blood cell lysis buffer 
(NH4Cl, KHCO3, EDTA) was added to the leaving un-
touched packet cells (erythrocytes and leukocytes). After 
30 min. of erythrocytes lysis in ice bath, aliquots were 
centrifuged at 4,000 rpm for 10 min at 4°C, and superna-
tants were discarded. The pellets containing leukocytes 
were washed twice with the phosphate-buffered saline 
(PBS), and total RNA was isolated as described below.
RNA extraction and real-time RT-PCR
Total RNA was extracted from leukocytes using a com-
mercially available acid-phenol reagent (TriReagent, 
Sigma-Aldrich, USA) according to the manufacturer’s 
instructions. RNA concentration and its purity were as-
sessed by a LAMBDA 25 UV spectrophotometer (Perki-
nElmer, UK) at UV260 and UV260/280, respectively. 4 µg total 
RNA was reverse-transcribed using a (dT)18 primer and 
RevertAid™ H Minus M-MuLV reverse transcriptase as 
described in the manufacturer’s protocol (Fermentas, 
Lithuania). The cDNA was diluted ten-fold, and 2 mL 
cDNA was used to perform RT-PCR using MaximaTM 
SYBR Green/ROX qPCR Master Mix (2 ×) (Thermo 
Scientific, USA) and specific primers for PIK3CD (for-
ward 5’–CAGCGACAACATCATGATCC–3’; reverse 
5’–TCGTAGGTGAGGATGAATGG–3’), and for glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH) as 
a housekeeping gene (forward 5’–GGTGGTCTCCTCT-
GACTTCAACA–3’; reverse, 5’–GTTGCTGTAGC-
CAAATTCGTTGT–3’). Amplification was carried out on 
7500 Real Time PCR System (Applied Biosystems, USA) 
with initial denaturation at 94°C for 3 min, followed by 
24 cycles at 94°C for 30s, 56°C for 15s, 72°C for 30s, and 
a final extension at 72°C for 1 min. All samples were run 
in duplicate. Specificity of the product was assessed 
from the melting curve analysis. The threshold cycle 
(Ct) of each target product was determined, and DCt 
between target and endogenous control GAPDH was 
calculated as: DCt = Ct (PI3KCD) – Ct (GAPDH). The expression 
changes between the GDM and the NGT groups were 
expressed as DDCt and calculated in the following man-
ner: DDCt = DCt (GDM) – DCt (NGT). The fold change value 
between the two groups was determined as 2 –DDCt [13].
Statistical analysis
The distribution of analysed data was checked by the 
chi-square test. Differences between variables were 
calculated using the Student’s t test (in the case of 
normally distributed data) or the Wilcoxon’s test (if 
the variables were not normally distributed). The cor-
relations were performed using the Spearman’s rank 
correlation method. The data was expressed as mean 
± standard deviation (SD). A P value < 0.05 was con-
sidered significant. Statistical analysis was performed 
using a commercially available statistical software pack-
age (Statistica version 8.0, StatSoft, Poland, licence no 
AXAP911E504325AR-K).
Results
Subject characteristics
The clinical characteristics of 132 GDM and 43 NGT 
patients are given in Table I. In univariate analyses, 
women complicated by GDM were older and had sig-
nificantly lower plasma HDL-C levels than the NGT 
group (P < 0.05). Fasting, 1-h and 2-h plasma glucose 
concentrations at 75 g OGTT as well as HbA1C levels 
were significantly higher in the GDM women compared 
to the NGT controls (P < 0.05). No significant differ-
ences existed in gestational age and the parameters 
of maternal adiposity (i.e. pre- and pregnancy BMI, 
body weight gain), lipid metabolism (i.e. TGs, LDL-C 
and total cholesterol [TC]), inflammation (CRP), insulin 
resistance (i.e. insulin, HOMA-IR), and insulin secretion 
(HOMA-B) between the two groups (P > 0.05).
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Leukocyte PIK3CD mRNA expression 
 and correlations
The changes in leukocyte PIK3CD gene expression in 
GDM (n = 132) v. NGT (n = 43) subjects were deter-
mined by RT-PCR. The PIK3CD mRNA level in these 
cells was significantly higher in the GDM group com-
pared to the control group (0.29 ± 0.24 v. 0.15 ± 0.14, 
P < 0.001 as assessed by the non-parametric Wilcoxon’s 
test) with a 1.98-fold up-regulation (Fig. 1). 
Univariate correlation analyses with the use of the 
Spearman rank test were performed to investigate 
whether the leukocyte PIK3CD expression is related 
to clinical characteristics of subjects given in Table I. 
As indicated in Table II, PIK3CD mRNA inversely cor-
related with fasting plasma levels of LDL-C (r = –0.303, 
P = 0.006) and TC (r = –0.259, P = 0.019) in the GDM 
group and the entire study population. There was also 
a significant positive correlation between the leukocyte 
PIK3CD mRNA and the plasma glucose concentration 
at 2 h of 75 g OGTT in the whole study population 
(r = 0.262, P = 0.001) (Fig. 2). In contrast, no correlations 
were observed between PIK3CD expression and other 
clinical parameters of subjects.
To further study the relationship between the leu-
kocyte PIK3CD expression and GDM, we examined the 
association between the leukocyte expression levels 
of PIK3CD and SIRT1. This correlation was rendered 
possible by the fact that SIRT1 mRNA level was re-
cently determined by our group in the same samples 
of patients with GDM and NGT as those used in the 
Table I. Clinical characteristics of studied women
Tabela I. Charakterystyka kliniczna kobiet uczestniczących w badaniu
Variable NGT group (n = 43) GDM group (n = 132) P
Age (years) 29.0 ± 4.7 30.6 ± 4.9 0.035a*
Gestational age (week) 29.3 ± 2.4 29.7 ± 2.6 0.380b
Pre-pregnancy BMI [kg/m2] 24.4 ± 4.5 25.2 ± 5.6 0.429b
Pregnancy BMI [kg/m2] 27.9 ± 4.3 28.8 ± 5.7 0.446a
Body weight gain [kg]  9.7 ± 5.4 9.5 ± 5.7 0.653b
Fasting plasma TC [mg/dL] 257.8 ± 39.5 249.8 ± 46.8 0.330a
Fasting plasma TGs [mg/dL] 230.7 ± 76.5 232.1 ± 86.6 0.988b
Fasting plasma HDL-C [mg/dL] 77.0 ± 16.4 69.6 ± 18.5 0.021a*
Fasting plasma LDL-C [mg/dL] 142.5 ± 58.1 139.0 ± 46.5 0.843b
HbA1c (%) 5.3 ± 0.4 5.5 ± 0.4 0.010
a*
Fasting plasma glucose [mg/dL] 78.5 ± 8.2 90.2 ± 19.1 < 0.001b*
1-h plasma glucose [mg/dL] 154.5 ± 34.3 185.0 ± 31.6 < 0.001b*
2-h plasma glucose [mg/dL] 114.1 ± 20.5 163.0 ± 21.5 < 0.001a*
Insulin [mlU/mL] 5.3 ± 3.9 4.7 ± 3.2 0.573b
HOMA-IR 1.2 ± 1.0 1.6 ± 1.3 0.057b
HOMA-B 137.2 ± 99.8 115.8 ± 77.9 0.444b
CRP [mg/L] 4.3 ± 3.2 3.9 ± 3.0 0.653b
BMI — body mass index; CRP — C reactive protein; HDL — high-density lipoprotein; HOMA-B — homeostasis model assessment of b-cell function; HOMA-IR — 
homeostasis model assessment of insulin resistance; LDL — low density lipoprotein; TC — total cholesterol; TGs — triglycerides. Data represents mean ± SD.  
aP value from Student’s t test; bP value from Wilcoxon’s test; *P value < 0.05 as statistically significant 
Figure 1. Boxplots of PIK3CD mRNA expression (AU — 
arbitrary units) in the NGT (n = 43) and GDM (n = 132) 
groups. Middle line: median; box: interquartile range; 
whisker: range (excluding outliers). P < 0.001 compared to 
the NGT group by the Wilcoxon’s test 
Rycina 1. Wykresy pudełkowe ekspresji PIK3CD mRNA 
(AU – jednostki arbitralne) w grupach NGT (n = 43) 
i GDM (n = 132). Środkowa linia: mediana; pudełko: zakres 
międzykwartylowy; wąsy: zakres wartości nieodstających. 
P < 0,001 jak porównano z grupą NGT
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present study. The leukocyte SIRT1 mRNA level was 
significantly increased in the GDM group (n = 109) 
v. the NGT group (n = 36) (0.93 ± 0.73 v. 0.58 ± 0.57, 
P = 0.014 as assessed by the non-parametric Wilcoxon’s 
test) [manuscript in preparation]. The Spearman test re-
vealed the positive correlation between the expression 
of PIK3CD and SIRT1 in the NGT (r = 0.451, P = 0.006) 
and GDM groups (r = 0.250, P = 0.009), as well as in the 
entire study population of pregnant women (n = 145; 
r = 0.350, P < 0.001) (Fig. 3).
Discussion
In the current study, to investigate a potential signifi-
cance of PI3-K delta in GDM, we evaluated leukocyte 
PIK3CD mRNA expression in the GDM v. NGT groups 
and its correlation with known parameters of lipid and 
glucose metabolism as well as indices of insulin resist-
ance and inflammation. 
A group consisting of 132 women complicated by 
GDM and another 43 NGT pregnant women at 24–33 
weeks of gestation was included in the study. The GDM 
women were older and had significantly lower HDL-C 
and higher HbA1c and glucose levels compared to the 
NGT subjects. Of note is that the NGT pregnant women 
had slightly greater HOMA-B and CRP values than the 
GDM subjects, even though the differences between the 
groups did not reach statistical significance. In regard 
to the HOMA-B index, evidence exists for its significant 
reduction in GDM v. NGT women [14, 15], suggest-
Figure 2. The positive correlation of leukocyte PIK3CD 
mRNA expression (AU — arbitrary units) with 2-h OGTT 
glucose plasma concentration in the entire study group of 
pregnant women (NGT + GDM; n = 145) 
Rycina 2. Dodatnia korelacja między ekspresją PIK3CD 
mRNA (AU — jednostki arbitralne) w leukocytach 
a stężeniem glukozy w osoczu w 2 godzinie OGTT w grupie 
wszytkich kobiet ciężarnych uczestniczących w badaniu 
(NGT + GDM; n = 145)
Table II. Correl ations of PIK3CD mRNA expression with clinical parameters of patients
Tabela II. Korelacje ekspresji PIK3CD mRNA z klinicznymi parametrami pacjentek
Variable NGT GDM NGT + GDM
r P r P r P
Age (years) –0.166 0.299  0.038 0.665  0.048 0.529
Gestational age (week) 0.122 0.677 –0.039 0.856 0.084 0.609
Pre-pregnancy BMI [kg/m2]  0.005 0.975 –0.064 0.472 –0.026 0.736
Pregnancy BMI [kg/m2] –0.015 0.929 –0.050 0.574 –0.020 0.795
Body weight gain [kg]  0.008 0.962 –0.022 0.799 –0.047 0.546
Fasting plasma TC [mg/dL] –0.279 0.122 –0.259 0.019* –0.281 0.002*
Fasting plasma TGs [mg/dL] –0.265 0.143 –0.055 0.621 –0.102 0.281
Fasting plasma HDL-C [mg/dL] –0.031 0.866 –0.017 0.877 –0.090 0.341
Fasting plasma LDL-C [mg/dL] –0.257 0.155 –0.303 0.006* –0.278 0.003*
HbA1c (%)  0.083 0.624  0.008 0.926  0.067 0.392
Fasting plasma glucose [mg/dL]  0.132 0.416 –0.063 0.490  0.082 0.301
1-h plasma glucose [mg/dL]  0.151 0.358 –0.131 0.194  0.059 0.491
2-h plasma glucose [mg/dL]  0.257 0.114  0.020 0.826  0.262 0.001*
Insulin [µlU/mL] –0.165 0.368  –0.171 0.135  –0.166 0.084
HOMA-IR 0.039 0.831  –0.161 0.179  –0.014 0.887
HOMA-B 0.000 1.000 –0.159 0.192 –0.140 0.175
CRP [mg/L]  –0.162 0.352 –0.049 0.640  –0.078 0.381
r- and P-values are given. Abbreviations as in Table I. *Significant correlation as assessed by Spearman’s correlation method
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ing an impairment in basal insulin secretory capacity 
during diabetic pregnancy that could be due to b-cell 
dysfunction partially resulting from b-cell apoptosis 
[16]. In the case of the inflammatory marker CRP, a non-
specific acute phase reactant that is primarily produced 
by the liver in response to inflammatory stimuli [17], 
its positive association with GDM has been reported 
[18, 19]. However, there is one study demonstrating 
that maternal plasma CRP level is not related to GDM, 
but rather correlates significantly with pre-pregnancy 
obesity [20]. Since the NGT and GDM groups were 
similar in terms of pre-pregnancy BMI in our study, it 
seems likely that the higher CRP concentration in the 
NGT subjects was not due to differences in adiposity. 
However, we cannot exclude the possibility that there 
were temporal variations in CRP levels during the day 
between normal and diabetic pregnancy [21].
The novel finding of our study was a 1.98-fold in-
crease in leukocyte PIK3CD mRNA level in the GDM 
women compared to the NGT pregnant controls in 
the third trimester of pregnancy, suggesting that GDM 
could affect alteration in PI3-K delta at its gene expres-
sion level. To date, most studies on the significance of 
PI3-K in GDM have concerned functional characteris-
tics of a p85 regulatory subunit [22, 23] and some have 
focused on evaluating the expression of PI3-K alpha 
and PI3-K beta catalytic subunits in muscle, adipose, 
and placental tissues of diabetic pregnant women [4, 
5]. However, their exact biological functions in the 
pathophysiology of GDM still remain obscure.
Oxidative stress, defined as excessive formation 
and/or insufficient removal of reactive oxygen species 
(ROS) and reactive nitrogen species (RNS), has been 
implicated in the ageing process as well as in the patho-
genesis of various diseases, including cancer, cardiovas-
cular diseases (atherosclerosis, ischaemic heart disease, 
hypertension, cardiomyopathies, cardiac hypertrophy, 
congestive heart failure), cataract, rheumatoid arthritis, 
neurodegenerative diseases (Alzheimer’s and Parkin-
son’s diseases), and diabetes [24, 25]. GDM has been 
shown to associate with enhanced oxidative stress 
[26], leading to increased inflammation, activation of 
metalloproteinases, and increased circulating levels 
of vascular molecules such as E-selectin and vascular 
cell adhesion molecule 1 (VCAM-1) [27]. Thus, a close 
relationship exists between oxidative stress, low-grade 
inflammation, and atherosclerosis in GDM. Since it has 
been shown that in vitro oxidative stress induces PI3-K 
delta signalling in monocytes and macrophages, and 
both PI3-K delta expression and signalling are increased 
in the lungs of patients with chronic obstructive disease 
(COPD) [28] where oxidative stress and inflamma-
tion are the main events in the pathogenesis of this 
disease, we cannot rule out the possibility that the 
leukocyte PIK3CD overexpression in the GDM women 
observed in our study might be related to enhanced 
oxidative stress and/or inflammation in the diabetic 
subjects. Although markers of oxidative stress and pro-
inflammatory cytokines that could confirm the above 
hypothesis have not been determined in this study, the 
positive linear correlation between leukocyte PIK3CD 
mRNA and 2 hour post-glucose plasma level found in 
the present study seems to support, at least partially, 
this concept. The available data suggests that hyper-
glycaemia induces oxidative stress through several 
metabolic mechanisms, including the polyol pathway, 
formation of advanced glycation endproducts (AGEs), 
activation of PKC, the hexosamine pathway, and en-
hanced ROS production in the mitochondria [27]. Thus, 
hyperglycaemia-induced oxidative stress might be one 
of the mechanisms underlying the leukocyte PIK3CD 
overexpression in the GDM women. On the other hand, 
Figure 3. The positive correlations between the expression of PIK3CD and SIRT1 (AU — arbitrary units) in leukocytes of 
pregnant women with (A) NGT (n = 36) and (B) GDM (n = 109), and (C) the entire study group of patients (NGT + GDM; 
n = 145) 
Rycina 3. Dodatnie korelacje między ekspresją PIK3CD a SIRT1 (AU – jednostki arbitralne) w leukocytach kobiet ciężarnych 
z (A) NGT (n = 36), (B) GDM (n = 109) oraz całej badanej grupie pacjentek (NGT+ GDM; n = 145)
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it is likely that the increased PIK3CD mRNA level in 
the diabetic patients could be due to inflammation state 
induced directly by hyperglycaemia [29, 30]. According 
to this assumption, it has been reported that PI3-K delta 
affects different cellular functions of leukocytes, and 
its inactivation leads to impaired inflammatory and 
immune responses [8]. Since there is a close relation-
ship between oxidative stress and inflammation, it is 
also possible that hyperglycaemia stimulates oxidative 
stress-mediated inflammation that is accompanied by 
the up-regulation of leukocyte PIK3CD mRNA in the 
GDM women. However, the sequence of events by 
which hyperglycaemia might affect leukocyte PIK3CD 
overexpression under diabetic conditions requires 
further detailed studies. 
Further interesting findings in the current study are 
the inverse correlations of leukocyte PIK3CD mRNA 
expression with plasma LDL-and TC levels in the GDM 
group. An elevated plasma LDL-C is currently believed 
to be a crucial pathogenic factor in the development of 
atherosclerosis, and statin treatment has been shown 
to decrease LDL-C level by 20–30% and reduce the 
incidence of coronary artery disease by 20–30% [31]. 
An increased LDL susceptibility to oxidation under 
oxidative stress conditions is one of the most important 
mechanisms in the development of atherosclerosis 
[32]. The oxidised LDL (ox-LDL) is taken up through 
macrophages scavenger receptor pathways, leading to 
the formation of cholesterol-loaded foam cells, essen-
tial components of atherosclerotic plaques [32]. A link 
between oxidative events and the process of atheroscle-
rosis during GDM has been found. In this regard, an 
increased LDL susceptibility to oxidation in pregnancies 
complicated by diabetes has been demonstrated [33]. 
Moreover, GDM has been shown to increase a patient’s 
risk of atherosclerosis and coronary heart disease [34]. 
From these considerations, the relationship between 
leukocyte PIK3CD overexpression under hypergly-
caemic conditions and decreased plasma LDL-and TC 
levels in the GDM group observed in our study sug-
gests that the PI3-K delta isoform could be a potential 
negative regulator of LDL-C and cholesterol metabo-
lism in diabetic subjects, which would protect against 
atherosclerosis. However, the underlying mechanisms 
by which PI3-K delta could affect plasma LDL-C level 
in diabetic patients need to be fully elucidated. 
Over the past years, SIRT1 has been considered as 
an essential modulator of glucose and lipid homeostasis 
in different metabolic tissues, including liver, skeletal 
muscle, and white adipose tissue, as well as insulin 
secretion by pancreatic b cells and inflammation [9, 
10]. Therefore, establishing whether SIRT1 is related 
to PI3-K delta in GDM was of great interest to us. We 
were able to correlate leukocyte mRNA levels of PIK3CD 
with SIRT1 in the same GDM and NGT subjects since 
leukocyte SIRT1 mRNA expression has also been deter-
mined in our laboratory [manuscript in preparation]. 
Interestingly, we found that SIRT1 and PIK3CD mRNA 
levels positively correlated with each other in the GDM 
subjects as well as in the NGT controls, suggesting the 
existence of a close relationship between them during 
normal and diabetic pregnancy. The reasons for these 
associations are currently unknown, but may reflect 
a protective role of SIRT1 against oxidative stress, which 
has been implicated in both normal and complicated 
pregnancy [27, 35]. In keeping with this, several studies 
in vitro and in vivo have revealed the protective effect of 
SIRT1 up-regulation in some cell types against oxidative 
stress. For example, Alcendor et al. [36] demonstrated 
that cardiac-specific Sirt11 overexpression at low to 
moderate levels (up to 7.5-fold) in transgenic mice 
protected their heart from oxidative stress through an 
increase of catalase expression via the forkhead box O 
proteins (FoxO)-dependent mechanism. Interestingly, 
a high level (12.5-fold) of Sirt1 increased apoptosis and 
hypertrophy and decreased cardiac function, thereby 
stimulating the development of cardiomyopathy [36]. 
A recent study in rodent models has also supported 
a protective function of cardiac-specific Sirt1 overexpres-
sion against oxidative stress [37]. In proximal tubular cell 
lines, Sirt1 was up-regulated with the enhancement of 
catalase expression under ROS-stimulated conditions 
[38]. Thus, it is possible that, at least partially, leukocyte 
SIRT1 overexpression in normal and diabetic pregnancy 
might protect against oxidative stress, but further study 
will be necessary in this field to address this hypothesis. 
Moreover, the positive associations of SIRT1 with PI3-K 
delta during human normal pregnancy and pregnancy 
complicated by GDM also remain to be established. 
Conclusions
In the past few years, the list of identified molecular 
factors linked to diabetic pregnancy has greatly expanded, 
although it is still far from complete [39, 40]. Since no 
published reports are accessible on a relationship of 
leukocyte PIK3CD mRNA with GDM, we conducted 
the present study to address this gap. 
Our data shows that leukocyte PIK3CD mRNA is 
overexpressed in GDM women in the third trimester of 
gestation and its expression level positively associates 
with 2 hour post-glucose plasma concentration as well 
as with leukocyte SIRT1 gene expression in the whole 
study population. 
The study also identifies the inverse correlations 
between leukocyte PIK3CD mRNA expression and 
plasma LDL-C and TC levels in the GDM group which 
should be analysed in greater detail to provide a new 
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insight into the role of PI3-K delta in lipid metabolism 
during diabetic pregnancy. 
The major limitation of our study is the lack of 
measurements of markers of oxidative stress and 
pro-inflammatory cytokines which probably would 
help to clarify the functional significance of the above-
mentioned associations. Therefore, additional studies 
are certainly needed to confirm our present findings in 
the context of the link between leukocyte PI3-K delta 
and oxidative stress and inflammation during GDM. 
Moreover, whether an elevated leukocyte PIK3CD 
mRNA expression persists during the postpartum 
period after pregnancy complicated by GDM is also 
unknown and worthy of further investigation. 
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